I was happy enough with what I read in oct 2020 invester presentation. Seems like if nothing else we will be able to change the lives of mice for the better. The normal process seems to be mice then larger animals then humans. Plenty of safety ant tolerability results in dogs have been shown also. Normal next step is humans.
re not anywhere near ready for human trials it would seem HREC approval has been given for burns trial so someone thinks they are ready. I think they stated they expect to dose first patient before end q1 2021 so not sure what is going on there if you are correct?
SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE), the company is developing new classes of synthetic anti-infectives, today announced it has received Human Research Ethics Committee (HREC) approval to start a Phase I/II clinical trial of its broad-spectrum antibiotic RECCE® 327 on patients with infected burn wounds.
re sepsis they have signed up paraxcel to conduct trials at cmax facility in South Australia. Interesting decision if they are absolutely nowhere near testing in humans?
from last 4c progressing iv trial. Interesting if still nowhere near. Phase I intravenous (I.V.) study of R327 at Adelaide’s CMAX clinical research institute continued to advance with clinicians appointed and an independent facility audit completed that ensures international regulatory standards.
It does sound like whatever thay do you will persist in criticising anyway so maybe best option is just to not buy?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)